Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis

Merel van Nuland, Steffie Groenland, Andre M. Bergman, Joris I. Rotmans, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)e383-e386
JournalClinical Genitourinary Cancer
Volume17
Issue number2
DOIs
Publication statusPublished - Apr 2019
Externally publishedYes

Keywords

  • Enzalutamide
  • Hemodialysis
  • Metabolites
  • Prostate cancer
  • Renal failure

Cite this